Parameters and pitfalls to consider in the conduct of food additive research, Carrageenan as a case study

Food and Chemical Toxicology

Volumn 87, Issue , 2016, Pages 31-44

  Weiner, Myra L ^a  

^a TOXpertise LLC   (United States)

Author keywords

Carrageenan; Food additive; NCM460 cells; Test methods; Vehicles

Indexed keywords

CARRAGEENAN; DRINKING WATER; FOOD ADDITIVE;

ARTICLE; ARTIFICIAL MILK; BIOCHEMICAL COMPOSITION; CALORIC INTAKE; CASE STUDY; CELL LINE; CHEMICAL PARAMETERS; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; HEPG2 CELL LINE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MATERIALS TESTING; MOLECULAR WEIGHT; NCM356 CELL; NCM460 CELL; NONHUMAN; PALATABILITY; PHYSICAL PARAMETERS; PROTEIN BINDING; STUDY DESIGN; VISCOSITY; WEIGHT GAIN; ANIMAL; CHEMISTRY; FOOD ANALYSIS; PROCEDURES; PRODUCT SAFETY; RISK ASSESSMENT; TOXICITY TESTING;

ANIMALS; CARRAGEENAN; CONSUMER PRODUCT SAFETY; FOOD ADDITIVES; FOOD ANALYSIS; HUMANS; MOLECULAR WEIGHT; RISK ASSESSMENT; TOXICITY TESTS;

EID: 84949292690     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2015.11.014     Document Type: Article

References (71)

1. Abraham R., Golberg L., Coulston F. Uptake and storage of degraded carrageenan in lysosomes of reticuloendothelial cells of the Rhesus monkey, Macaca Mulatta. Exp. Mol. Path 1972, 17:77-93.
2. Beattie I.A., Blakemore W.R., Dewar E.T., Warwick M.H. A study of orally-administered degraded carrageenan in the baboon. Food Cosmet. Toxicol. 1970, 8:257-266.
3. Beattie I.A., Blakemore W.R., Dewar E.T., Warwick M.H. Corrigendum to "A study of orally-administered degraded carrageenan in the baboon. Food Cosmet. Toxicol. 2014, 8(1970):257-266. Food Chem. Toxicol. 75, 189. http://dx.doi.org/10.1016/j.fxt.2014.10.012.
4. Beck M.J. A 10-day Infant Formula Feeding Toxicity and Toxicokinetic Study of Carrageenan in Neonatal Gottingen Minipigs. WIL Study 105056 (FMC Study 12011-2374), WIL Research Laboratory, Ashland, OH, USA. Dossier Prepared by FMC Corporation 2012, USA, and the International Formula Council, Philadelphia, PA, (Submitted to WHO by the Republic of the Philippines).
5. Benitz K.F., Golberg L., Coulston F. Intestinal effects of carrageenans in the Rhesus monkey. Food Cosmet. Toxicol. 1973, 11:565-575.
6. Bhattacharyya S., Borthakur A., Anbazhagan A.N., Katyal S., Dudeja P.K., Tobacman J.K. Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301(3):G475-G486.
7. Bhattacharyya S., Borthakur A., Dudeja P.K., Tobacman J.K. Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro. J. Nutr. 2008, 138(3):469-475.
8. Bhattacharyya S., Borthakur A., Dudeja P.K., Tobacman J.K. Carrageenan reduces bone morphogenetic protein-4 (BMP4) and activates the Wnt/beta-catenin pathway in normal human colonocytes. Dig. Dis. Sci. 2007, 52(10):2766-2774.
9. Bhattacharyya S., Borthakur A., Tyagi, Gill R., Chen M.L., Dudeja P.K., Tobacman J.K. B-Cell CLL/Lymphoma 10 (BCL10) is required for NF-κB production by both canonical and noncanonical pathways and for NF-κB-inducing Kinase (NIK) Phosphorylation. J. Biol. Chem. 2010, 285(1):522-530.
10. Bhattacharyya S., Dudeja P.K., Tobacman J.K. Carrageenan-induced NFκB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10. Biochim. Biophys. Acta 2008, 1780(7-8):973-982.
11. Bhattacharyya S., Dudeja P.K., Tobacman J.K. Tumor necrosis factor α-induced inflammation is increased but Apoptosis is inhibited by common food additive carrageenan. J. Biol. Chem. 2010, 285(50):39511-39522.
12. Bhattacharyya S., Feferman L., Tobacman J.K. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, Chrondroitin 4-Sulfate, and Galectin-3. J. Biol. Chem. 2014, 289(25):17564-17575.
13. 307-IRS1. J. Biol. Chem. 2015, 290(17):10764-10774.
14. Bhattacharyya S., Gill S., Chen M.L., Zhang F., Linhardt R.J., Dudeja P.K., Tobacman J.K. Toll-like receptor 4 mediates induction of Bcl10-NFκB-IL-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J. Biol. Chem. 2008, 283(16):10550-10558. http://www.jbc.org/cgi/doi/10.1074/jbc.M708833200.
15. Bhattacharyya S., Liu H., Zhang Z., Jam M., Dudeja P.K., Michel G., Linhardt R.J., Tobacman J.K. Carrageenan-induced innate immune response is modified by enzymes that hydrolyze distinct galactosidic bonds. J. Nutr. Biochem. 2010, 21(10):906-913.
16. Bhattacharyya S., O-Sullivan I., Katyal S., Unterman T., Tobacman J.K. Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signaling in HepG2 cells and C57BL/6J mice. Diabetologia 2012, 55(1):194-203.
17. Bhattacharyya S., Tobacman J.K. Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B. J. Nutr. Biochem. 2012, 23:1058-1063.
18. Bixler H. Food Safety: Refuting Myths about Carrageenan. Food Processing 2013, http://www.foodprocessing.com/articles/2013/refuting-myths-about-carrageenan.html.
19. Blakemore W.R., Harpell A.R. Chapter 5: Carrageenan. Food Stabilisers, Thickeners and Gelling Agents 2010, Wiley-Blackwell, Blackwell Publishing Ltd, (Published Online). A. Imeson (Ed.).
20. Blakemore W.R., Davis S.R., Hroncich M.M., Vurma M. Carrageenan analysis. Part 1: characterisation of the carrageenan test material and stability in swine-adapted infant formula. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2014, 31(10):1661-1669. 10.1080/19440049.2014.955536.
21. Blakemore W.R., Kwok S.K., Harding N.I. Carrageenan analysis. Part 2: quantification in swine-adapted infant formula. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 2014, 31(10):1670-1672. 10.1080/19440049.2014.955537.
22. Blakemore W.R., Brant A.F., Bissland J.G., Bissland N.D. Carrageenan analysis. Part 3. Quantitation in swine plasma. Food Addit. Contam. Part A 2014, 31(10):1673-1677. 10.1080/19440049.2014.955538.
23. Borthakur A., Bhattacharyya S., Anbazhagan A.N., Kumar A., Dudeja P.K., Tobacman J.K. Prolongation of carrageenan-induced inflammation in human colonic epithelial cells by activation of an NFκB-BCL10 loop. Biochem. Biophys. Acta 2012, 1822:1300-1307.
24. Borthakur A., Bhattacharyya S., Dudeja P.K., Tobacman J.K. Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292(3):G829-G838.
25. Canadian Gazette (2004). Vol. 138, No. 20. May 15, Item A.5. Available from: . http://www.hc-sc.gc.ca/fn-an/securit/addit/list/4-emulsifeng.php.
26. Choi H.J., Kim H.G., Kim J., Park S.H., Park J., Oh C.G., Do K.H., Lee S.J., Park Y.C., Ahn S.C., Kim Y.S., Moon Y. Pro-apoptotic action of macrophage inhibitory cytokine 1 and counteraction of activating transcription factor 3 in carrageenan-exposed enterocytes. Tox Lett. 2014, 231:1-8.
27. Commission Regulation Off. J. Eur. Union 2012, 231/2012 of 9 March, 2012, L83 55 L 83/140 - L 83/141.
28. Davidson T.L., Swithers S.E. Food viscosity influences caloric intake compensation and body weight in rats. Obes. Res. 2005, 13:537-544.
29. Donnelly E.T., Bardwell H., Thomas G.A., Williams E.D., Hoper M., Crowe P., McCluggage W.G., Stevenson M., Phillips D.H., Hewer A., Osborne M.R., Campbell F.C. Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical. Carcinogenesis 2004, 25:847-855.
30. Engster M., Abraham R. Cecal response to different molecular weights and types of carrageenan in the guinea pig. Toxicol. Appl. Pharmacol. 1976, 38:265-282. https://eurl-ecvam.jrc.ec.europa.eu/The%20European%20Union%20Reference%20Laboratoryfor%20alternatives%20to%20animal%20testing%20(EURL-ECVAM).
31. European Food Safety Authority (EFSA) Scientific opinion of the panel on food additives, flavourings, processing aids and materials in contact with food on a request from European Commission on Neotame as a sweetener and flavor enhancer. EFSA J. 2007, 581:1-43. http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/afc_op_ej581_neotame_op_en,3.pdf.
32. European Commission Health & Consumer Protection Directorate-general, Opinion of the Scientific Committee on Food on Carrageenan 2003, SCF/CS/ADD/EMU/199 Final. http://europa.eu.int/comm/food/fs/sc/scf.
33. Food and Agriculture Organization (FAO) of the United Nations Combined Compendium of Food Additive Specifications; CGN - 79th Session of JECFA, 2014 2014.
34. Food and Drug Administration (FDA) Toxicological Principles for the Safety Assessment of Food Ingredients: Redbook 2000, Available from:. http://www.fda.gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/ingredientsadditivesgraspackaging/ucm2006826.htm.
35. Food and Drug Administration (FDA) Toxicological Principles for the Safety Assessment of Food Ingredients: Redbook, Revised 2007. Redbook 2000 Guidance for Industry and Other Stakeholders Toxicological Principles for the Safety Assessment of Food Ingredients Redbook 2000 2007, U.S. Department of Health and Human Services Food and Drug Administration Center for Food Safety and Applied Nutrition, July 2000; Updated July 2007. http://www.fda.gov/downloads/Food/GuidanceRegulation/UCM222779.pdf.
36. Food and Drug Administration (FDA) Food and Drug Administration Good Laboratory Practices for Non-clinical Laboratory Studies 2014, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRsearch.cfm?CFRPart=58.
37. Food Chemical Codex FCC Carrageenan Monograph 2015, ninth ed.
38. IFAC International Food Additives Council Good Manufacturing Practice and Quality Assurance Guide for Food Additives and GRAS Substances 2013, http://foodadditives.org/pdf/IFAC-GMP-QA-Guide.pdf.
39. INCELL Normal Derived Colon Mucosa (NMC460) INCELL NCM460 Product Information 2007v1.0 2007, http://www.ibrarian.net/navon/paper/INCELL_Corporation__LLC.pdf?paperid=10444614.
40. INCELL Letter from Mary Pat Moyer, CEO and Chief Science Officer to Customers: Regarding the Status of Human NCM Cell Lines Derived from Human Normal Colon Mucosa, April 21, 2015 2015.
41. INCELL Letter from Mary Pat Moyer, CEO and Chief Science Officer to Customers: Regarding the Cytogenetic Studies of the Human NCM Cell Lines, May 1, 2015 2015.
42. International Agency for Research on Cancer (IARC) Monograph Carrageenan 1983, 31:79-94.
43. International Programme on Chemical Safety in cooperation with the Joint FAO/WHO Expert Committee on Food Additives (JECFA) Principles for the Safety Assessment of Food Additives and Contaminants in Food, Environmental Heath Criteria 70 1987, WHO, Geneva.
44. International Programme on Chemical Safety (IPCS) Environmental Health Criteria 240 Principals and Methods for the Risk Assessment of Chemicals in Food 2009, Available from:. http://www.who.int/foodsafety/chem/principles/en/index1.html.
45. Japan Food Additives Association Japan's Specifications for Food Additives 2009, 344. the Ministry of Health and Welfare, (English Translation). eighth ed.
46. Jia L., Liu X. The conduct of drug metabolism studies considered good practice (II): In vitro experiments. Curr. Drug Metab. 2007, 8(8):822-829.
47. JECFA: Joint FAO/WHO Expert Committee on Food Additives 68th report of the Joint FAO/WHO Expert Committee on food additives; evaluation of certain food additives and contaminants. WHO Tech. Rep. Ser. 2008, 947:32-37.
48. Joint FAO/WHO Expert Committee on Food Additives (JEFCA) Safety evaluation of certain food additives. WHO Food Addit. Ser. 2015, 70. Prepared by the Seventy-ninth meeting of the Joint FAO/WHO Expert Committee on Food Additives. http://apps.who.int/iris/bitstream/10665/171781/3/9789240693982_eng.pdf?ua=1.
49. Lee S.K., Il Kim T., Kim Y.K., Choi C.H., Yang K.M., Chae B., Kim W.H. Cellular differentiation-induced attenuation of LPS response in HT-29 cells is related to the down-regulation of TLR4 expression. Biochem. Biophys. Res. Commun. 2005, 337:457-463.
50. Mankes R., Abraham R. Lysosomal dysfunction in colonic, submucosal macrophages of Rhesus monkeys caused by degraded iota carrageenan (38996). Proc Soc Exp Biol Med 1975, 150:166-170.
51. Mayhew D.A., Comer C.P., Stargel W.W. Food consumption and body weight changes with neotame, a new sweetener with intense taste: differentiating effects of palatability from toxicity in dietary studies. Regul. Toxicol. Pharmacol. 2003, 38:124-143.
52. McGill H.C., McMahan C.A., Wigodsky H.S., Sprinz H. Carrageenan in formula and infant baboon development. Gastroenterology 1977, 73:512-517.
53. McKim J.M. Food additive Carrageenan: part I: a critical review of carrageenan in vitro studies, the potential pitfalls, and implications for human health and safety. Crit. Rev. Toxicol. 2014, 44(3):211-243.
54. McKim J.M., Wilga P.C., Pregenzer J.F., Blakemore W.R. The common food additive carrageenan is not a ligand for Toll-Like-Receptor 4 (TLR4) in an HEK293-TLR4 reporter cell-line model. Food Chem. Toxicol. 2015, 78:153-158.
55. Michel C., MacFarlane G.T. Digestive fates of soluble polysaccharides from marine macroalgae: involvement of the colonic microflora and physiological consequences for the host. J. Appl. Bacteriol. 1996, 80:349-369.
56. Moirano A. Sulfated seaweed polysaccharides. Food Colloids 1977, 367. AVI Publishing Company, (Chapter 8). H. Graham (Ed.).
57. Moyer M.P., Manzano L.A., Merriman R.L., Stauffer J.S., Tanzer L.R. Letter to the Editor: NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell. Dev. Biol. 1996, 32:315-317.
58. Nicklin S., Miller K. Effect of orally administered food grade carrageenans on antibody-mediated and cell-mediated immunity in the inbred rat. Food Chem. Tox 1984, 22(8):615-621.
59. Organization of Economic Cooperation and Development (OECD) The OECD Guidelines for the Testing of Chemicals Section 4 Health Effects 2015, http://www.oecd-ilibrary.org/environment/oecd-guidelines-for-the-testing-of-chemicals-section-4-health-effects_20745788.
60. Pittman K.A., Golberg L., Coulston F. Carrageenan: the effect of molecular weight and polymer type on its uptake, excretion and degradation in animals. Fd. Cosmet. Toxicol. 1976, 14:85-93.
61. Poulsen E. Short-term peroral toxicity of undegraded carrageenan in pigs. Fd. Cosmet. Toxicol. 1973, 11:219-277.
62. Scientific Committee for Food On Emulsifiers Stabilizers, Thickeners and Gelling Agents 30 November, 1978.
63. Simiantonak i N., Kurzik-Dumke U., Karyofylli G., Jayasinghe C., Michel-Schmidt R., Kirkpatrick C.J. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int. J. Mol. Med. 2007, 20:21-29.
64. Tobacman J.K. Filament disassembly and loss of mammary myoepithelial cells after exposure to lambda-carrageenan. Cancer Res. 1997, 57(14):2823-2826.
65. Tobacman J.K. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ. Health Perspect. 2001, 109(10):983-994.
66. Tobacman J.K., Walters K.S. Carrageenan-induced inclusions in mammary myoepithelial cells. Cancer Detect Prev. 2001, 25(6):520-526. http://www.toxicology.org/about/history/docs/poster_press/91x42_AIR_poster_press.pdf#search=%22replacing%20animals%20in%20studies%22%20in%20the%20United%20States.
67. United Stated Adopted Names Council (USAN) List No. 297 new names, poligeenan. Clin. Pharmacol. Ther. 1988, 44(2):246-248.
68. Uno Y., Omoto T., Goto Y., Asai I., Nakamura M., Maitani T. Molecular weight and fecal Excreted quantity of carrageenan administered to rats in blended feed. Jpn. J. Food Chem. (JJFC) 2001, 8:83-93.
69. Weiner M.L. Food additive Carrageenan: part II: a critical review of carrageenan in vivo safety studies. Crit. Rev. Toxicol. 2014, 44(3):244-269.
70. Weiner M.L., et al. A 90-day dietary study of kappa carrageenan with emphasis on the gastrointestinal tract. Food Chem. Toxicol. 2007, 45:98-106.
71. Weiner M.L., et al. An infant formula toxicity and toxicokinetic feeding study on carrageenan in preweaning piglets with special attention to the immune system and gastrointestinal tract. Food Chem. Toxicol. 2015, 77:120-131.